NettetEli Lilly and Company. Eudract number. 2024-003270-64. Duration of Study in the UK. 3 years, 0 months, 9 days. ... LY3475070 is an orally available drug that works by binding/inhibiting a protein on the outside of the CD73 molecule. LY3475070 has been studied in laboratory and animal trials. NettetLead Sponsor: Eli Lilly and Company Collaboratore: Merck Sharp & Dohme LLC Fonte: Eli Lilly and Company Breve riassunto: Il motivo di questo studio è vedere se l'inibitore CD73 LY3475070 da solo o in combinazione con pembrolizumab è sicuro ed efficace nei partecipanti con cancro avanzato.
LY-3475070 CD markers 抑制剂 现货供应 美国品牌 - selleck
NettetFind technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes links to find associated … Nettet30. jan. 2024 · Eli Lilly cuts 3 cancer drugs amid Q4 clear-out. It’s that time of year when Big Pharmas are reporting revenues and zeroing in on the pipeline updates they want … calgary hotels macleod trail
Klinische Studien zur Fortgeschrittener Krebs: LY3475070, …
Nettet24. nov. 2024 · Glucagon-like peptide-1 receptor (GLP-1R) agonists are efficacious antidiabetic medications that work by enhancing glucose-dependent insulin secretion and improving energy balance. Currently approved GLP-1R agonists are peptide based, and it has proven difficult to obtain small-molecule activators p … NettetLY-3475070 (LY3475070; LY 3475070) is a novel, potent, oral and selective CD73 inhibitor (cluster of differentiation 73, IC50 = 28 nM) with potential anticancer activity. NettetKatri Lylynperä. 2,841 likes · 3 talking about this. Olen Sastamalasta kotoisin oleva maastohiihtäjä. Seuraa urheilijaelämääni tältä sivulta! calgary hotels near sait